• DRAMP ID

    • DRAMP29069
    • Peptide Name

    • CPF-2-2 (Variant of CPF-C1)
    • Source

    • Synthetic construct
    • Family

    • Not found
    • Gene

    • N/A
    • Sequence

    • kFwSLLkKAlrLwAkVL
    • Sequence Length

    • 17
    • UniProt Entry

    • No entry found
    • Protein Existence

    • Synthetic form
    • Biological Activity

    • Antimicrobial, Antibacterial, Anti-Gram+
    • Target Organism

      • [Ref.32590058] Gram-positive: S. aureus ATCC 25923 (MIC = 8 μg/mL, MIC = 128 μg/mL in 10% serum, MIC = 8 μg/mL in 150 mM, MBIC50 = 16 μg/mL, MBIC90 = 16 μg/mL, MBEC = 16 μg/mL), MRSA ATCC 33591 (MIC = 8 μg/mL), MRSA 054 isolated from clinics (MIC = 8 μg/mL), MRSA 023 isolated from clinics (MIC = 8 μg/mL), MRSA 113 isolated from clinics (MIC = 8 μg/mL), MRSA 048 isolated from clinics (MIC = 8 μg/mL), MRSA 002 isolated from clinics (MIC = 8 μg/mL), MRSA 074 isolated from clinics (MIC = 8 μg/mL), MRSA 051 isolated from clinics (MIC = 16 μg/mL), MRSA 052 isolated from clinics (MIC = 8 μg/mL), MRSA 075 isolated from clinics (MIC = 8 μg/mL), MRSA 071 isolated from clinics (MIC = 8 μg/mL), MRSA 936 isolated from clinics (MIC = 8 μg/mL), S. aureus 725 (MIC = 16 μg/mL), S. aureus 794 (MIC = 8 μg/mL)
    • Hemolytic Activity

      • [Ref.32590058]It showed almost no hemolytic activity, even at concentrations up to 128 μg/ml
    • Cytotoxicity

      • Not found
    • Binding Target

    • Bacterial membrane
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Amidation
    • Nonterminal Modifications and Unusual Amino Acids

    • Introduction of D-amino acid(s). (Look at 'Stereochemistry')
    • Stereochemistry

    • Mixed (D-Lys1, D-Trp3, D-Lys7, D-Leu10, D-Arg11, D-Trp13 and D-Lys15)
    • Structure

    • α-helical (most likely)
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP29069 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP29069.
    • Formula

    • C105H170N26O19
    • Absent Amino Acids

    • CDEGHIMNPQTY
    • Common Amino Acids

    • L
    • Mass

    • 2100.67
    • PI

    • 11.33
    • Basic Residues

    • 5
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 11
    • Net Charge

    • +5
    • Boman Index

    • -62
    • Hydrophobicity

    • 0.406
    • Aliphatic Index

    • 143.53
    • Half Life

      • Mammalian:1.3 hour
      • Yeast:3 min
      • E.coli:2 min
    • Extinction Coefficient Cystines

    • 11000
    • Absorbance 280nm

    • 687.5
    • Polar Residues

    • 1

DRAMP29069

    • Comment

    • CPF-2 has potential as a lead compound to treat infections caused by S. aureus and MRSA, including the associated biofilms.
  • ·Literature 1
    • Title

    • CPF-C1 analog with effective antimicrobial and antibiofilm activities against Staphylococcus aureus including MRSA
    • Reference

    • Biochimie. 2020 Sep;176:1-11. doi: 10.1016/j.biochi.2020.06.003. Epub 2020 Jun 23.
    • Author

    • Xie J, Li Y, Guo X, Rao J, Yan T, Mou L, Wu X, Xie X, Yang W, Zhang B.